Etiology of the metabolic syndrome: Potential role of insulin resistance, leptin resistance, and other players

Annals of the New York Academy of Sciences

Volumn 892, Issue , 1999, Pages 25-44

  Zimmet, Paul ^a   Boyko, E J ^a   Collier, G R ^b   De Courten, M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INSULIN; LEPTIN;

ADIPOCYTE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONFERENCE PAPER; FATTY ACID METABOLISM; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR;

EID: 0032796327     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07783.x     Document Type: Conference Paper

References (78)

1. 1. Zimmet, P. 1989. Non-insulin-dependent (Type 2) diabetes mellitus - Does it really exist? Diabetic Med. 6: 728-735.
2. 2. Zimmet, P. Z. 1995. The pathogenesis and prevention of diabetes in adults. Diabetes Care 18: 1050-1064.
3. 3. Zimmet, P. & K. G. M. M. Alberti. 1997. The changing face of macrovascular disease in non-insulin dependent diabetes mellitus in different cultures: an epidemic in progress. Lancet 350(Suppl. 1): S1-S4.
4. 4. Kaplan, N. M. 1989. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridaemia, and hypertension. Arch. Int. Med. 149: 1514-1520.
5. 5. Reaven, G. M. 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
6. 6. De Fronzo, R. & E. Ferrannini. 1991. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194.
7. 7. Zimmet, P. 1992. Challenges in diabetes epidemiology - from West to the rest. Diabetes Care 15: 232-252.
8. 8. Haffner, S. M., M. P. Stern, H. P. Hazuda, et al. 1990. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263: 2893-2898.
9. 9. Alberti, K. G. M. M. & P. Z. Zimmet for the World Health Organization Consultation. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med. 15: 539-553.
10. 10. Laakso, M. 1993. How good a marker is insulin level for insulin resistance? Am. J. Epidemiol. 137: 959-965.
11. 11. Jarrett, R. J. 1995. In defense of insulin: A critique of syndrome X. Lancet 340: 469-471.
12. 12. Stern, M. P. 1995. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes 44: 369-374.
13. 13. Collins, V. R., G. K. Dowse, C. F. Finch, et al. 1990. An inconsistent relationship between insulin and blood pressure in three Pacific island populations. J. Clin. Epidemiol. 43: 1369-1378.
14. 14. Zimmet, P. Z., V. R. Collins, G. K. Dowse, et al. 1994. Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Diabetic Med. 11: 388-396.
15. 15. Zimmet, P. 1999. Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 42: 499-518.
16. 16. De Courten, M., P. Zimmet & A. Hodge. 1997. Hyperleptinaemia: the missing link in the Metabolic Syndrome? Diabetic Med. 14: 200-208.
17. 17. Vague, J. 1956. The degree of masculine differentiation of obesity: a factor determining predisposition to diabetes, arteriosclerosis, gout and uric calculus disease. Am. J. Clin. Nutr. 4: 20-34.
18. 18. Bergman, R. N., R. Prager, A. Volund, et al. 1987. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 79: 790-800.
19. 19. De Fronzo, R. A., J. D. Tobin & R. Andres. 1979. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237: E214-E223.
20. 20. Matthews, D., J. Hosker, A. Rudenski, et al. 1985. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
21. 21. Dowse, G., H. Qin, V. Collins, et al. 1990. Determinants of estimated insulin resistance and B-cell function in Indian, Creole and Chinese Mauritians. Diabetes Res. Clin. Practice 10: 265-279.
22. 22. Leyva, F., I. F. Godsland, M. Ghatei, et al. 1997. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 18: 928-933.
23. 23. Austin, M. A. & K. L. Edwards. 1996. Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes. Curr. Opin. Lipidol. 7(3): 167-171.
24. 24. Edwards, K. L., M. A. Austin, B. Newman, et al. 1994. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler. Thromb. 14(12): 1940-1945.
25. 25. Edwards, K. L., C. M. Burchfiel, D. S. Sharp, et al. 1998. Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am. J. Epidemiol. 147(5): 441-447.
26. 26. Meigs, J. B., R. B. D'Agostino, Sr., P. W. Wilson, et al. 1997. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46(10): 1594-1600.
27. 27. Gray, R. S., R. R. Fabsitz, L. D. Cowan, et al. 1998. Risk factor clustering in the insulin resistance syndrome. The Strong Heart Study. Am. J. Epidemiol. 148(9): 869-878.
28. 28. Hodge, A. M., M. DeCourten, P. Z. Zimmet et al. 1998. Insulin links metabolic syndrome components in non-diabetic Mauritians. Diabetes 47(Suppl. 1): A150 (Abstr.).
29. 29. Tooke, J. E. 1998. Endotheliopathy precedes Type 2 diabetes. Diabetes Care 21: 2047-2048.
30. 30. Ferrannini, E., S. M. Haffner, B. D. Mitchell, et al. 1991. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416-422.
31. 31. Zhang, Y., R. Proenca, M. Maffei, et al. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
32. 32. Pelleymounter, M., M. Cullen, M. Baker, et al. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543.
33. 33. Chua, S. C., Jr., W. K. Chung, X. S. Wu-Peng, et al. 1996. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (Leptin) receptor. Science 271: 994-996.
34. 34. Bouchard, C., Ed. 1994. Genetics of obesity. CRC Press. Boca Raton, FL.
35. 35. Maffei, M., J. Halaas, E. Ravussin, et al. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1(11): 1155-1161.
36. 36. Considine, R. V., M. K. Sinha, M. L. Heiman, et al. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334: 292-295.
37. 37. Zimmet, P., A. Hodge, M. Nicolson, et al. 1996. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. Br. Med. J. 313: 965-969.
38. 38. Zimmet, P. Z., V. R. Collins, M. P. De Courten, et al. 1998. Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Int. J. Obesity. 21: 171-177.
39. 39. O'Rahilly, S. 1998. Life without leptin. Nature 392: 330-331.
40. 40. Auwerx, J. & B. Staels. 1998. Leptin. Lancet 351: 737-742.
41. 41. Donahue, R. P., P. Zimmet, J. A. Bean, et al. 1999. Is fasting leptin associated with insulin resistance among nondiabetic persons? The Miami Community Health Study. Diabetes Care 22: 1092-1096.
42. 42. Haffner, S. M., H. Miettinen, L. Mykkänen, et al. 1997. Leptin concentrations and insulin sensitivity in normoglycemic men. Int. J. Obesity 21: 393-399.
43. 43. De Silva, A. M., K. R. Walder, T. J. Aitman, et al. 1999. Combination of polymorphisms in OB-R and the OB gene associated with insulin resistance in Nauruan males. Int. J. Obesity. In press.
44. 44. Chessler, S. D., W. Y. Fujimoto, J. B. Shofer, et al. 1998. Increased plasma leptin levels are associated with fat accumulation in Japanese Americans. Diabetes 47: 239-243.
45. 45. Barnett, M., G. R. Collier, F. M. Collier, et al. 1994. A cross-sectional and short-term longitudinal characterization of NIDDM in the sand rat. Diabetologia 37: 671-676.
46. 46. Habito, R., M. Barbett, A. Yamamoto, et al. 1995. Basal glucose turnover in Psammomys obesus. An animal model of type 2 (non-insulin-dependent) diabetes mellitus. Acta Diabetol. 32: 187-192.
47. 47. Collier, G. R., A. De Silva, A. Sanigorski, et al. 1997. Development of obesity and insulin resistance in the Israeli Sand rat (Psammomys obesus): Does leptin play a role? Ann. N.Y. Acad. Sci. 827: 50-63.
48. 48. Walder, K., M. Willet, P. Zimmet, et al. 1997. Ob (obese) gene expression and leptin levels in Psammomys obesus. Biochem. Biophys. Acta 1354: 272-278.
49. 49. Walder, K., P. Lewandowski, A. Sanigorski, et al. 1999. Leptin administration has no effect on food intake, body weight or diabetic status in a multigenic model of obesity: Psammomys obesus. Int. J. Obesity 22: 1-7.
50. 50. Campfield, L. A., F. J. Smith, Y. Guisez, et al. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549.
51. 51. Neel, J. V. 1962. Diabetes mellitus: a thrifty genotype rendered detrimental by 'progress'? Am. J. Hum. Genet. 14: 353-362.
52. 52. Dowse, G. & P. Zimmet. 1993. The thrifty genotype in non-insulin-dependent diabetes. The hypothesis survives. Br. Med. J. 306: 532-533.
53. 53. Lee, G. H., R. Proenca, J. M. Montez, et al. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635.
54. 54. Cohen, B., D. Novick & M. Rubinstein. 1997. Modulation of insulin activities by leptin. Science 274: 1185-1188.
55. 55. Shimanukuro, M., K. Koyama, G. Chen, et al. 1997. Direct antidiabetic effects of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA 94: 4637-4641.
56. 56. Walder, K., A. Pilippis, S. Clark, et al. 1997. Leptin inhibits insulin binding in isolated rat adipocytes. J. Endocrinol. 155: R5-R7.
57. 57. Emilsson, V., Y.-L. Liu, M. A. Cawthorne, et al. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46: 313-336.
58. 58. Porte, D., R. J. Seeley, S. C. Woods, et al. 1998. Obesity, diabetes and the central nervous system. Diabetologia 41: 863-881.
59. 59. Pinkney, J. H., C. D., Stehouwer, S. W. Coppack, et al. 1997. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 46(Suppl. 2): S9-13.
60. 60. Johnstone, M. T., S. J. Creager, K. M. Scales, et al. 1993. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88(6): 2510-2516.
61. 61. McVeigh, G. E., G. M. Brennan, G. D. Johnston, et al. 1992. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35(8): 771-776.
62. 62. Steinberg, H. O., H. Chaker, R. Leaming, et al. 1996. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J. Clin. Invest. 97(11): 2601-2610.
63. 63. Chowienczyk, P. J., G. F. Watts, J. R. Cockcroft, et al. 1992. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340(8833): 1430-1432.
64. 64. Steinberg, H. O., B. Bayazeed, G. Hook, et al. 1997. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation 96(10): 3287-3293.
65. 65. Panza, J. A., P. R. Casino, C. M. Kilcoyne, et al. 1994. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J. Am. Coll. Cardiol. 23(7): 1610-1616.
66. 66. Conlan, M. G., A. R. Folsom, A. Finch, et al. 1993. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb. Haemostasis 70(3): 380-385.
67. 67. Cooke, J. P. & V. J. Dzau. 1997. Nitric oxide synthase: role in the genesis of vascular disease. Annu. Rev. Med. 48: 489-509.
68. 68. Williams, S. B., A. B. Goldfine, F. K. Timimi, et al. 1998. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97(17): 1695-1701.
69. 69. Anastasiou, E., J. P. Lekakism, M. Alevizaki, et al. 1998. Impaired endothelium-dependent vasodilation in women with previous gestational diabetes. Diabetes Care 21(12): 2111-2115.
70. 70. Makimattila, S., A. Virkamaki, P. H. Groop, et al. 1996. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 94(6): 1276-1282.
71. 71. Leeson, C. P., P. H. Whincup, D. G. Cook, et al. 1997. Flow-mediated dilation in 9-to 11-year-old children: the influence of intrauterine and childhood factors. Circulation 96(7): 2233-2238.
72. 72. Scherrer, U., D. Randin, P. Vollenweider, et al. 1994. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 94(6): 2511-2515.
73. 73. Steinberg, H. O., G. Brechtel, A. Johnson, et al. 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94(3): 1172-1179.
74. 74. Baron, A. D., H. O. Steinberg, H. Chaker, et al. 1995. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J. Clin. Invest. 96(2): 786-792.
75. 75. Yki-Jarvinen, H. & T. Utriainen. 1998. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 41: 369-379.
76. 76. Sniderman, A. D., K. Cianflone, L. K. M. Arner, et al. 1998. The adipocyte, fatty acid trapping, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 18: 147-151.
77. 77. Cianflone, K., M. Maslowska & A. D. Sniderman. 1998. Acetylation stimulating protein (ASP), an adipocyte autocrine: new directions. Cell Dev. Biol. In press.
78. 78. Cianflone, K. 1997. Obesity and the adipocyte. Acetylation stimulating protein and the adipocyte. J. Endocrinol. 155: 203-206.